Tenovi and GenieMD Partner to Expand Remote Care and Boost Medication Adherence GenieMD and Tenovi have teamed up to enhance access to healthcare through innovative virtual care models, combining their strengths to offer a more seamless and connected healthcare experience.…
Flosonics Medical Secures $7.5M CAD Venture Debt to Scale Wearable Ultrasound Tech Flosonics Medical, a Canadian innovator in medical devices, has secured $7.5 million CAD in venture debt financing from RBCx. This funding, along with specialized support, will help accelerate…
QIAGEN Takes Legal Action to Protect IP in QuantiFERON and Latent TB Testing QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA) has filed a lawsuit against bioMérieux SA (EPA: BIM) for patent infringement, emphasizing its dedication to safeguarding the scientific…
BostonGene to Present AI-Powered Platform at 22nd Annual Japanese Society of Medical Oncology Meeting BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced its participation in the 22nd Annual Meeting of the Japanese Society of Medical Oncology…
Phase III Study: Xolair More Effective with Fewer Side Effects Than Oral Immunotherapy for Food Allergies Genentech, a member of the Roche Group, has announced new positive results from Stage 2 and Stage 3 of the NIH-sponsored Phase III OUtMATCH…
Incyte to Present New Dermatology Data at 2025 AAD Meeting Incyte (Nasdaq: INCY) today announced that several abstracts showcasing new data from its dermatology portfolio will be presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting, set to…
BeiGene Reports Q4 & Full Year 2024 Financial Results and Update BeiGene, Inc. (NASDAQ: ONC, HKEX: 06160, SSE: 688235), soon to be rebranded as BeOne Medicines Ltd., a global leader in oncology pharmaceuticals, has announced its fourth-quarter and full-year 2024…
BridgeBio Oncology and Helix Acquisition Announce Merger to Create Biotech Company BridgeBio Oncology Therapeutics (BBOT), a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for RAS and PI3Kα-targeted malignancies, and Helix Acquisition Corp. II (Nasdaq: HLXB), a special…
Astria Therapeutics Launches Phase 3 ALPHA-ORBIT Trial of Navenibart for Hereditary Angioedema Astria Therapeutics, Inc. (Nasdaq: ATXS), a biopharmaceutical company dedicated to developing transformative therapies for allergic and immune diseases, has announced the launch of the Phase 3 ALPHA-ORBIT clinical…
Sierra Space to Support Cancer Research on First Dream Chaser® Mission to ISS Sierra Space, a leading commercial space company and defense technology provider, announced new initiatives to advance biopharmaceutical research in low-Earth orbit during the inaugural mission of its…
athenahealth Showcases AI, Interoperability, and Market Solutions at HIMSS 2025 athenahealth, a leading provider of network-enabled software and services for healthcare practices across the country, will be showcasing its innovations at HIMSS, taking place March 3-6. The company will highlight…
Validic Unveils Health IoT and Remote Patient Management Solutions with Generative AI on AWS Marketplace Validic, a leader in healthcare technology innovation, has announced the launch of its full suite of Intelligent Digital Care Solutions and Services on AWS Marketplace.…